FDA Approval of Inhaled Insulin Has Been Life-Changing for This Teen with Diabetes

**New Hope for Children and Adolescents with Type 1 Diabetes** Afrezza, an innovative inhaled insulin, has been approved by the FDA for children and adolescents.

**New Hope for Children and Adolescents with Type 1 Diabetes**

Afrezza, an innovative inhaled insulin, has been approved by the FDA for children and adolescents. This game-changing treatment offers a needle-free option that can significantly improve the lives of young people living with type 1 diabetes.

Taisie Seigrist, a 15-year-old who participated in the clinical trial for Afrezza, shares her inspiring story. Diagnosed with type 1 diabetes at just 10 years old, Taisie's condition required constant management and insulin injections. However, these shots caused discomfort, affected her quality of life, and even led to feelings of isolation.

Before discovering Afrezza, Taisie relied on mealtime injected insulin shots, which she administered up to seven times a day. This regimen was not only painful but also limited her participation in activities, such as sports, due to the time required for insulin absorption and action.

Managing Type 1 Diabetes: Challenges and Solutions

Dr. Michael Glazier, Chief Medical Officer at Bluebird Kids Health, highlights the difficulties associated with mealtime insulin administration, particularly in children and adolescents. The challenges include varying schedules, feelings of denial or rebellion, and the stigma associated with injection administration.

A New Hope: Afrezza Clinical Trial

Taisie's endocrinologist introduced her to the Afrezza clinical trial during a routine appointment in 2024. This innovative treatment involves inhaling mealtime insulin before eating, eliminating the need for painful injections. As Taisie shares, "Afrezza has changed my life." By participating in this groundbreaking study, young people with type 1 diabetes can now experience improved management and quality of life.

Learn more about hair transplant at Rubenhair clinic.